Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01849393 · ClinicalTrials.gov registry record

Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents

A clinical trial of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
100
Enrollment target
1
Study location

NCT01849393 is a study of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 100 participants, below the 503-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01849393, a study of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this project is to assess the study population's acceptance of two medication adherence support strategies: incentive-based programs and electronic medication monitoring. The study population is adolescents (ages 16 - 24) positive for human immunodeficiency virus (HIV) currently undergoing treatment with antiretrovirals at St. Jude's HIV clinic. Participation in the study will involve completion of a survey: an Audio Computer Assisted Self Interview (ACASI). The duration of the survey is anticipated to be 10-20 minutes. Patient identifiers will not be attached the survey.

Interventions

  • OTHER Questionnaire

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-06
Est. Completion 2013-12

What the Registry Record Tells You About NCT01849393

The ClinicalTrials.gov registry entry for NCT01849393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 503-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (80% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.

NCT01849393 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01849393 about?

NCT01849393 is a clinical study titled "Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents". The primary objective of this project is to assess the study population's acceptance of two medication adherence support strategies: incentive-based programs and electronic medication monitoring. The study population is adolescents (ages 16 - 24) positive for human immunodeficiency virus (HIV) curre...

What is the current status of trial NCT01849393?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2013-12.

What conditions does trial NCT01849393 study?

This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV), Acquired Immunodeficiency Syndrome (AIDS).

What interventions are being tested in trial NCT01849393?

The interventions under investigation include: Questionnaire (OTHER).

Who is sponsoring clinical trial NCT01849393?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01849393 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Immunodeficiency Virus (HIV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.